United Therapeutics · Health Care
UTHR
$535.67
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing.UnitedTherapeuticsCorporation是一家美国生物技术公司，致力于开发与器官移植（包括异种移植）相关的药物和技术。该公司的许多产品专注于肺部疾病和器官制造。
Secular growth长期成长
Large cap大盘
$23B
Engine stance引擎立场2026-07-20
Hold off — timing against you暂缓 — 时机不利
Downtrend — stand aside until a new cycle low forms and confirms.下跌趋势——观望，直至新的周期低点形成并确认。
Key Statistics关键统计
Price价格
$535.67
10.2% below 52-week high低于52周高点 10.2%
Market Cap市值
$23B
Normal volume正常成交量
P/E Ratio市盈率
17.5x
28.9x sector median
Beta贝塔
0.05
Moves about 0.1x the market波动幅度约为市场的 0.1 倍
RSI (14)RSI（14）
44
Neutral zone中性区域
Next Earnings下次财报
2026-07-29 (10d)
Volatility Rank波动率分位
39th pctile
hist. vol. percentile历史波动率分位数
Short Interest空头兴趣
4.8% of float
Performance价格表现
| Period周期 | UTHR | S&P 500 | vs Index对比指数 |
|---|---|---|---|
| 1 Week近1周 | -2.1% | -1.5% | In line with the index与指数基本持平 |
| 1 Month近1月 | -2.9% | +0.6% | Lagged the index by 3.5 points落后指数 3.5 个百分点 |
| 3 Months近3月 | -9.0% | +4.7% | Lagged the index by 13.7 points落后指数 13.7 个百分点 |
| 6 Months近6月 | +15.2% | +7.8% | Beat the index by 7.4 points跑赢指数 7.4 个百分点 |
| Year to date年初至今 | +7.8% | +9.1% | Lagged the index by 1.3 points落后指数 1.3 个百分点 |
| 1 Year近1年 | +80.2% | +19.4% | Beat the index by 60.8 points跑赢指数 60.8 个百分点 |
| 3 Years近3年 | +125.2% | +69.4% | Beat the index by 55.8 points跑赢指数 55.8 个百分点 |
Technicals技术面
RSI (14)RSI（14）
44
Neutral zone中性区域
vs 50-day相对50日均线
-3.3% vs 50-day avg
vs 200-day相对200日均线
+5.0% vs 200-day avg
Volatility rank波动率分位
39th percentile 分位
Engine reference levels — not advice引擎参考水平 — 非投资建议
Stop止损
$526.70
Blocked — failed cycle受阻 — 失败周期
Earnings财务业绩
10
days until next report天后公布财报
2026-07-29
Estimates being cut预期下调
Earnings call transcripts — coming soon财报电话会议记录 — 即将上线
Valuation估值
| Multiple指标 | UTHR | Sector median行业中位 | Cheaper than相对便宜 |
|---|---|---|---|
| P/E (trailing)市盈率（历史） | 17.52x | 28.92 | 82% |
| P/B市净率 | 3.29x | 3.52 | 52% |
| P/S市销率 | 7.35x | 3.02 | 17% |
| Earnings yield盈利收益率 | 5.71% | 2.72 | 87% |
| FCF yield自由现金流收益率 | 4.45% | 3.94 | 56% |
| Shareholder yield股东收益率 | 4.28% | 1.89 | 80% |
| EV/EBITDA企业价值/EBITDA | 13.83x | 18.21 | 70% |
| P/FCF市值/自由现金流 | 22.46x | 22.42 | 49% |
Analyst price targets — coming soon分析师目标价 — 即将上线
Financials财务数据
Revenue营业收入
5yr CAGR5年复合增速: 16.5%
Earnings Per Share每股收益
5yr CAGR5年复合增速: 19.3%
Free Cash Flow自由现金流
Margins利润率
18.8%Return on Equity股本回报率
16.9%Return on Assets资产回报率
Leverage杠杆
| Net debt / EBITDA净债务/EBITDA | -0.99 |
| Current ratio流动比率 | 6.60 |
Capital Allocation资本配置
| Buybacks (TTM)回购（TTM） | $1.0B |
| Stock-based comp股权薪酬 | $147.7M |
| Share count change (1y)股数变化（1年） | -2.7% |
Piotroski皮奥特罗斯基 7/8
Altman Z阿尔特曼Z: safe (20.9)
Clean稳健
Snapshot Gauges综合指标
Valuation vs Sector估值相对行业
Looks cheap vs sector相对行业偏便宜
Cheaper than 55% of its sector on blended multiples综合估值倍数低于行业内 55% 的公司
Beta市场敏感度
0.05×
0.21×3×
Moves about 0.1× the market波动幅度约为市场的 0.1 倍
Financial Health财务健康
7/8
Altman阿尔特曼: safe
Strong financial health财务健康状况良好
Dividend分红
—
Does not pay a dividend不派发股息
Why Is It Moving为何波动
Macro宏观
Long-duration name into a restrictive, rising-real-rate regime → rate headwind.长久期标的进入偏紧、实际利率上行的环境→利率逆风。
Positioning持仓
Insider cluster activity内部人集中交易
Technical技术面
UTHR StochRSI turned up from oversoldUTHR StochRSI自超卖区上行
Ownership & Smart Money持仓与聪明钱
Insider activity内部人员活动: -$589.8M net (0 buyers, 12 sellers)-$589.8M 净值（0 买家，12 卖家）
Signal History信号历史
DECLINE
DOWNTREND
Jul 17, 2026
UTHR StochRSI turned up from oversoldUTHR StochRSI自超卖区上行
StochRSI popped back above 20 — the earliest oscillator heads-up that downside momentum is easing. $535.67.StochRSI重回20上方 — 下行动量趋缓的最早预警。$535.67。
Jul 14, 2026
UTHR daily MACD crossed downUTHR 日线MACD下穿
The daily MACD histogram turned negative — fast and noisy, context rather than a standalone trigger. $526.66.日线MACD柱状图转负 — 快速且嘈杂，仅作背景。$526.66。
Jul 10, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jul 10, 2026
UTHR broke down vs the marketUTHR 相对市场走弱
Relative strength vs SPY crossed below the 10th percentile of the last 90 days — weakness often leads price. $547.06.相对标普500的强弱下穿近90日的第10百分位 — 走弱常先于价格。$547.06。
Jul 9, 2026
UNCONFIRMED TURN → UPTREND未确认转向 → 上涨趋势
HOLD持有
Jul 1, 2026
NEARING A LOW → UPTREND接近低点 → 上涨趋势
HOLD持有
Jun 25, 2026
UPTREND → NEARING A LOW上涨趋势 → 接近低点
GET READY准备
Jun 24, 2026
TOPPING → UPTREND做顶中 → 上涨趋势
HOLD持有
Jun 24, 2026
TOPPING → UNCONFIRMED TURN做顶中 → 未确认转向
HIGH-RISK · NIMBLE ONLY高风险 · 仅限灵活操作
Jun 24, 2026
UTHR daily MACD crossed upUTHR 日线MACD上穿
The daily MACD histogram turned positive — fast and noisy, context rather than a standalone trigger. $549.90.日线MACD柱状图转正 — 快速且嘈杂，仅作背景。$549.90。
Showing last 15 of显示最近15条，共 260 signals条信号
Factor Profile因子特征
Composite factor score综合因子得分: -0.13
Value价值
-0.3
Profitability盈利能力
+0.2
Quality质量
-0.2
Investment资本投入
+0.1
Shareholder payout股东回报
+0.1
Low volatility低波动
-0.6
Low market beta低市场敏感度
+1.1
Earnings quality盈利质量
-0.3
Short interest空头兴趣
+0.5
Company Profile公司档案
United Therapeutics Corporation is an American biotechnology company that develops pharmaceuticals and technologies related to organ transplantation, including xenotransplantation. Many of the company's products are focused towards lung disease and organ manufacturing.UnitedTherapeuticsCorporation是一家美国生物技术公司，致力于开发与器官移植（包括异种移植）相关的药物和技术。该公司的许多产品专注于肺部疾病和器官制造。
Watch items — what could change the thesis关注项 — 可能改变论点的因素
- Margin compression despite revenue growth
- Receivables stretch
- Capital intensity rising
Get the full picture获取完整视图
Nightly signals, options flow, and factor analysis across all S&P 500 names.每日更新的信号、期权资金流向和因子分析，覆盖所有标普500成分股。